clinical trials
It’s because of Evergreen’s commitment to – and experience within – the cancer research community that we’re able to offer our patients trials in a number of phases and indications. In fact, Dr. Stephen P. Anthony is the only physician in the Spokane area qualified to offer Phase 1 (first in-human) clinical trials.
Some of our recent work in the area of clinical trials includes the following:
- adjuvant breast cancer HER2-positive early-stage breast cancer
- metastatic first-line non-small-cell lung cancer
- first-line stage IIIB or IV non-squamous non-small-cell lung cancer
- second-line treatment of patients with locally advanced or metastatic non-small-cell lung cancer
- metastatic first-line pancreatic cancer
- metastatic second-line pancreatic cancer
- metastatic first-line malignant melanoma
- adjuvant for node-negative or high-risk node-negative HER2-negative breast cancer
- second-line stage IIIB/IV or recurrent non-squamous non-small-cell lung cancer
For more information about the availability of clinical trials and how to qualify, email us or call 509.464.CURE